temperature for 48 h (follow the reaction by TLC). The reaction
was quenched with Na2S2O4 (1.2 g in 10 mL of water). After 24
additional hours of stirring, the aqueous phase was extracted
with AcOEt. The combined organic layers were washed with
brine, dried over MgSO4, filtered, and evaporated. The purifica-
tion by FC (cyclohexane/AcOEt 2/1) gave ((3) (380 mg, 83%) as
a white-gray solid: mp 142 °C; TLC Rf 0.29 (cyclohexane/AcOEt
3/2); IR (CHCl3) νmax 3500, 3020, 1530, 1350 cm-1; 1H NMR (400
MHz, CDCl3) δ 3.37 (d, J ) 4.5 Hz, 2 H), 5.60 (d, J ) 4.5 Hz, 2
H), 7.45 (td, J ) 8, 1.3 Hz, 2 H), 7.62 (td, J ) 7.8, 1.3 Hz, 2 H),
7.78 (dd, J ) 5, 1.3 Hz, 2 H), 7.80 (dd, J ) 5.2, 1.3 Hz, 2 H);
13C NMR (100 MHz, CDCl3) 71.9, 124.5, 129.0, 129.5, 133.2,
134.8, 148.6; MS (EI) m/z (%) 152 (13), 135 (56), 121 (68), 93
(48), 77 (75), 65 (72), 51 (100); HR-MS 152.0334 (C7H6O3N calcd
152.0347).
2 H), 7.83 (dd, J ) 7.8, 1.3 Hz, 1 H), 7.90 (m, 3 H); 13C NMR
(100 MHz, CDCl3) 14.1, 22.7, 23.9, 29.3, 29.6, 29.7, 31.9, 34.2,
80.3, 80.6, 106.2, 124.4, 124.7, 128.2, 128.7, 129.0, 129.1, 133.5,
133.7, 133.9, 134.6, 148.3, 148.4; MS (EI) m/z (%) 315 (41), 152
(17), 135 (100), 104 (15); HR-MS 315.0626 (C15H11O6N2 calcd
315.0617; C26H34O6N2-C11H23).
4,5-Bis(2-n it r op h en yl)-2-p h en et h yl[1,3]d ioxola n e (5d ).
Following the general procedure, the hydrocinnamaldehyde 4d
(67 mg, 0.5 mmol) and the diol ((3) (167 mg, 0.55 mmol) in the
presence of PPTS (12.5 mg, 0.05 mmol) gave 5d (160 mg, 85%)
as a yellow oil: TLC Rf 0.43 (cyclohexane/AcOEt 3/1); IR (CHCl3)
νmax 3030, 2930, 2865, 1530, 1350, 1135, 1035 cm-1 1H NMR
;
(400 MHz, CDCl3) δ 2.27 (m, 2 H), 2.93 (m, 2 H), 5.53 (t, J ) 4.7
Hz, 1 H), 5.65 (ab, J ab ) 6.5 Hz, 2 H), 7.23-7.36 (m, 5 H), 7.52
(m, 2 H), 7.73 (m, 2 H), 7.82 (dd, J ) 7.8, 1.3 Hz, 1 H), 7.93 (m,
3H); 13C NMR (100 MHz, CDCl3) 30.0, 35.7, 80.4, 80.6, 105.2,
124.4, 124.7, 126.0, 128.2, 128.4, 128.5, 128.6, 129.0, 129.1, 133.4,
133.5, 133.6, 134.4, 141.0, 148.3, 148.4; MS (EI) m/z (%) 315 (3),
165 (3), 152 (13), 135 (100), 119 (14); HR-MS 315.0620
(C15H11O6N2 calcd 315.0617; C23H20O6N2-PhCH2CH2).
(1R,2R)-1,2-Bis(2-n itr oph en yl)eth an e-1,2-diol ((-)-3). NMO
(50% in water, 530 µL, 2.5 mmol) was added to a solution of
trans-stilbene 2 (540 mg, 2 mmol), (DHQD)2PHAL (20 mg, 0.025
mmol), CH3SO2NH2 (190 mg, 2 mmol), and OsO4 (4% in water,
130 µL, 0.02 mmol). The mixture was stirred at 0 °C for 4 h.
The enantiomeric excess was determined, after FC (cyclohexane/
AcOEt 2/1), by SFC (Chiralcel ODH, 0.46 cm L × 25 cm, 15%
2,3-Bis(2-n itr op h en yl)-1,4-d ioxa -sp ir o[4.5]d ec-6-en e (5e).
Following the general procedure, the cyclohexenone 4e (24 mg,
0.25 mmol) and the diol ((3) (76 mg, 0.25 mmol) in the presence
of PPTS (7 mg, 0.025 mmol) gave 5e (79 mg, 83%) as a yellow
oil: TLC Rf 0.25 (cyclohexane/AcOEt 9/1); IR (CHCl3) νmax 2930,
MeOH in CO2, 200 bar CO2, 30 °C, T1 ) 4.3 min (1R,2R), T2
)
4.8 min (1S,2S); 93% ee). Recrystallization in toluene gave (-)-3
(142 mg, 82%, 99% ee) as white-gray crystals: mp 172 °C; [R]17
D
-30.1 (4.7 mg‚mL-1, CHCl3).
2855, 1530, 1350, 1220, 1205, 1115 cm-1 1H NMR (400 MHz,
;
Gen er a l P r oced u r e for th e Aceta liza tion . In a flask under
argon equipped with a Dean-Stark water separator, a solution
of distilled aldehyde or ketone (1 mmol), 1,2-diol 3 (1.0-1.2
mmol) and pyridinium p-toluenesulfonate (PPTS, 25 mg, 0.1
mmol) in 10 mL of dry benzene were stirred at reflux. After
completion of the reaction (monitored by TLC), the benzene was
distilled and AcOEt was added. The organic phase was washed
once with a satd NaHCO3 solution and once with brine, dried
over MgSO4, filtered, and evaporated. The residue was purified
by FC (silica gel, cyclohexane/AcOEt).
CDCl3) δ 1.90 (m, 2 H), 2.13 (m, 4 H), 5.53 (ab, J ab ) 8.1 Hz, 2
H), 5.91 (d, J ) 9.9 Hz, 1 H), 6.13 (dt, J ) 10.1 Hz, 1 H), 7.48
(td, J ) 8.1, 1.3 Hz, 2 H), 7.72 (td, J ) 7.8, 1.3 Hz, 2 H), 7.81
(dd, J ) 8.1, 1.3 Hz, 2 H), 7.97 (dd, J ) 8.1, 1.3 Hz, 2 H); 13C
NMR (100 MHz, CDCl3) 20.6, 24.8, 34.8, 79.4, 79.9, 106.9, 124.3,
127.5, 128.9, 129.1, 129.2, 132.1, 132.1, 133.4, 133.5, 134.1, 148.8;
MS (EI) m/z (%) 354 (3), 135 (100), 97 (11), 91 (34); HR-MS
354.0857 (C18H14O6N2 calcd 354.0852; C20H18O6N2-C2H4).
2-Hex-1-en yl-4,5-bis(2-n itr op h en yl)[1,3]d ioxola n e (5f).
Following the general procedure, the trans-heptenal 4f (28 mg,
0.25 mmol) and the diol ((3) (91 mg, 0.3 mmol) in the presence
of PPTS (7 mg, 0.025 mmol) gave 5f (88 mg, 88%) as a yellow
oil: TLC Rf 0.31 (cyclohexane/AcOEt 3/1); IR (CHCl3) νmax 2930,
2855, 1530, 1350, 1130, 1035 cm-1; 1H NMR (400 MHz, CDCl3)
δ 0.92 (t, J ) 7.2 Hz, 3 H), 1.25-1.50 (m, 4 H), 2.16 (q, J ) 7.1
Hz, 2 H), 5.68 (ab, J ab ) 6.1 Hz, 2 H), 5.75-5.80 (m, 2 H), 6.12
(dt, J ) 6.6 Hz, 1 H), 7.51 (td, J ) 7.8, 1.0 Hz, 2 H), 7.71 (qd, J
) 8.3, 1.0 Hz, 2 H), 7.74-7.94 (m, 4 H); 13C NMR (100 MHz,
CDCl3) 13.9, 22.2, 30.6, 31.8, 80.1, 80.6, 105.8, 124.5, 124.8,
125.3, 128.2, 128.8, 129.1, 133.5, 133.7, 133.9, 134.2, 139.8, 148.3,
148.5; MS (EI) m/z (%) 287 (1), 152 (4), 135 (100), 91 (34), 79
(44); HR-MS 287.0643 (C14H11O5N2 calcd 287.0668; C21H22O6N2-
C7H11O).
2-Decyl-2-m et h yl-4,5-b is(2-n it r op h en yl)[1,3]d ioxola n e
(5a ). Following the general procedure, the dodecan-2-one 4a (46
mg, 0.25 mmol) and the diol ((3) (91 mg, 0.3 mmol) in the
presence of PPTS (7 mg, 0.025 mmol) gave 5a (108 mg, 92%) as
a pale yellow oil: TLC Rf 0.55 (cyclohexane/AcOEt 3/1); IR
1
(CHCl3) νmax 2930, 2855, 1525, 1350 cm-1; H NMR (400 MHz,
CDCl3) δ 0.88 (t, J ) 6.8 Hz, 3 H), 1.20-1.40 (m, 14 H), 1.58 (m,
2 H), 1.66 (s, 3 H), 1.94 (m, 2 H), 5.46 (ab, J ab ) 8.1 Hz, 2 H),
7.48 (m, 2 H), 7.73 (t, J ) 7.6 Hz, 2 H), 7.79 (d, J ) 8.3 Hz, 2 H),
7.97 (td, J ) 8.1, 1.3 Hz, 2 H); 13C NMR (100 MHz, CDCl3) 14.1,
22.7, 24.2, 25.0, 29.3, 29.5, 29.6, 29.9, 31.9, 40.4, 79.4, 80.2, 111.4,
124.2, 128.9, 129.0, 129.1, 131.9, 132.3, 133.4, 148.9; MS (EI)
m/z (%) 329 (35), 152 (11), 135 (100), 104 (15), 91 (40); HR-MS
329.0782 (C16H13O6N2 calcd 329.0774; C26H34O6N2-C10H21).
2,3-B i s (2-n i t r o p h e n y l)-1,4-d i o x a -s p i r o [4.11]h e x a -
d eca n e (5b). Following the general procedure, the cyclodode-
canone 4b (182 mg, 1 mmol) and the diol ((3) (304 mg, 1 mmol)
in the presence of PPTS (25 mg, 0.1 mmol) gave 5b (350 mg,
75%) as a white solid: mp 153-154 °C; TLC Rf 0.45 (cyclohex-
ane/AcOEt 5%); IR (CHCl3) νmax 3020, 2935, 2850, 1525, 1470,
1360, 1220, 1115 cm-1; UV (MeCN) λmax (ꢀ) 210 (20300), 252
4-Ch olesten -3-on e, (1R,2R)-1,2-Bis(2-n itr oph en yl)eth an e-
1,2-d iol Keta l (5g). The 4-cholesten-3-one 4g (58 mg, 0.15
mmol), the diol (-)-3 (46 mg, 0.15 mmol), and PPTS (4 mg, 0.015
mmol) were stirred at 80 °C in dry benzene with molecular sieves
4 Å (at 110 °C in dry toluene only the deconjugated product was
observed). The organic phase was washed once with a satd
NaHCO3 solution and once with brine, dried over MgSO4,
filtered, and evaporated. The purification by FC (cyclohexane/
1
(7500); H NMR (400 MHz, CDCl3) δ 1.40 (m, 14 H), 1.60 (m, 4
AcOEt 9/1) gave 5g (68 mg, 67%) as a thick orange oil: [R]17
D
H), 1.98 (m, 4 H), 5.46 (s, 2 H), 7.47 (td, J ) 8.0, 1.3 Hz, 2 H),
7.72 (td, J ) 7.8, 1.3 Hz, 2 H), 7.78 (dd, J ) 8.3, 1.3 Hz, 2 H),
7.95 (dd, J ) 8.1, 1.3 Hz, 2 H); 13C NMR (100 MHz, CDCl3) 20.1,
22.2, 22.5, 25.8, 26.2, 33.4, 79.7, 114.1, 124.2, 129.0, 129.1, 132.0,
133.4, 149.0; MS (EI) m/z (%) 468 (1, M+•), 300 (1), 254 (3), 237
(5), 181 (3), 135 (100), 120 (13); HR-MS 300.1962 (C19H26O2N
calcd 300.1963).
+158.3 (8.7 mg‚mL-1, CHCl3); TLC Rf 0.48 (cyclohexane/AcOEt
3/1); IR (CHCl3) νmax 3025, 2950, 2870, 1705, 1655, 1610, 1580,
1525, 1465, 1350, 1100, 1010 cm-1; 1H NMR (400 MHz, CDCl3)
δ 0.70 (s, 3 H), 0.85-2.35 (m, 40 H), 5.55 (s, 2 H), 5.62 (s, 1 H),
7.47 (m, 2 H), 7.70-7.80 (m, 4 H), 7.96 (dd, J ) 7.1, 1.0 Hz, 1
H), 8.05 (d, J ) 7.0 Hz,1 H); 13C NMR (125 MHz, CDCl3)
12.0, 17.9, 18.6, 21.2, 22.5, 22.8, 23.8, 24.2, 28.0, 28.2, 28.9, 31.7,
32.3, 32.6, 34.2, 35.7, 35.8, 36.1, 38.7, 39.5, 39.8, 42.5, 53.4,
56.0, 56.1, 68.2, 79.7, 80.1, 107.4, 119.6, 124.2, 124.3, 128.8,
129.0, 129.1, 130.9, 132.3, 132.5, 133.4, 133.5, 148.9, 149.0, 153.5;
MS (EI) m/z (%) 491 (1), 400 (26), 384 (44), 369 (9), 342 (17),
271 (13), 261 (23), 247 (22), 229 (47), 124 (83), 93 (65), 55
(100); HR-MS 384.3378 (C27H44O calcd 384.3392; C41H54O6N2-
4,5-Bis(2-n itr op h en yl)-2-u n d ecyl[1,3]d ioxola n e (5c). Fol-
lowing the general procedure, the lauraldehyde 4c (92 mg, 0.5
mmol) and the diol ((3) (182 mg, 0.6 mmol) in the presence of
PPTS (12.5 mg, 0.05 mmol) gave 5c (210 mg, 90%) as a pale
yellow solid: mp 49-50 °C; TLC Rf 0.54 (cyclohexane/AcOEt 3/1);
IR (CHCl3) νmax 2930, 2855, 1530, 1350, 1265, 1205, 1140, 1035
cm-1 1H NMR (400 MHz, CDCl3) δ 0.88 (t, J ) 6.8 Hz, 3 H),
;
C
14H10O5N2).
1.20-1.40 (m, 16 H), 1.56 (m, 2 H), 1.92 (m, 2 H), 5.48 (t, J )
4.6 Hz, 1 H), 5.61 (ab, J ab ) 6.6 Hz, 2 H), 7.50 (m, 2 H), 7.72 (m,
Gen er a l P r oced u r e for th e P h otoch em ica l Dep r otec-
tion . The acetal (0.1 mmol) and an internal standard (tetrade-
1140 J . Org. Chem., Vol. 68, No. 3, 2003